Skip to main content
. 2021 Feb 24;12:607966. doi: 10.3389/fimmu.2021.607966

Table 4.

CTLA-4 and PD-1 haplotype frequencies of the PSS patients and healthy controls.

Frequency (%) p P c OR 95% CI
PSS 2n = 274 Control 2n = 278
CTLA-4 rs733618-rs4553808-rs5742909-rs231775-rs3087243
TACAA 26.37 19.86 0.070 0.139 1.45 0.97−2.15
TGTAG 14.29 10.11 0.134 0.179 1.48 0.88−2.49
CACGG 29.30 41.16 0.004 0.015 0.60 0.42−0.85
TACGG 30.04 28.88 0.767 0.766 1.06 0.73−1.53
PD-1 rs10204525-rs2227981-rs2227982-rs41386349-rs36084323
TAGAC 20.80 19.11 0.639 0.639 1.11 0.73−1.68
CAGGC 7.30 4.52 0.203 0.609 1.61 0.77−3.35
CGGGC 20.07 17.46 0.420 0.630 1.19 0.78−1.83
TGAGC 0.73 3.27 0.034 0.204 0.22 0.05−1.02
TAGAT 0.73 1.82 0.450 0.540 0.40 0.08−2.07
TGAGT 50.36 53.82 0.395 0.790 0.87 0.62−1.21

Values in bold indicate significant differences. The p value was calculated using χ2 test or Fisher’s exact test and corrected for multiple testing using the FDR method. PSS, Posner-Schlossman syndrome; Pc: corrected p value; OR, odds ratio; CI, confidence interval.